The Stock Market Is Doing Something Witnessed Only 2 Times in 153 Years -- and History Is Very Clear About What May Happen in ...
There is profound transformation coming over the next decades. It will unlock the equivalent of a century of change every ...
In other news, the US House passes a bill barring federal agencies from procuring items from ‘biotechnology companies of ...
Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...
In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...
A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
Quick Links Sheel Biotech Ltd. Quick Links Stock Summary Cash Flow Statement Half Yearly Results Capital Structure Chairman's Speech Company History Locations Dividends Splits Competitors Historical ...
When GLP-1 drugs like Ozempic and Wegovy hit the market, they didn’t just change how doctors treat obesity - they changed how investors think about medicine itself. A single biologic began to displace ...
Lexicon Pharmaceuticals is positioned for a potential turnaround with three key drug programs and recent partnerships, despite a challenging history. LXRX's sotagliflozin faces uncertain FDA approval ...
A wave of potentially lucrative licensing deals has swept across China's biopharma sector in recent months, but investors have not been impressed. From RemeGen in July to InnoCare Pharma and Hansoh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback